AI Agent Operational Lift for Evoke Health in New York, New York

Why AI matters at this scale

Evoke Health operates at the intersection of science and creativity, crafting omnichannel marketing solutions for pharmaceutical and life sciences clients. With 200-500 employees and a 2006 founding, the agency sits in a sweet spot: large enough to generate proprietary campaign data and invest in technology, yet agile enough to adopt AI faster than lumbering holding companies. The healthcare marketing sector is undergoing a seismic shift as personalization and real-time optimization become table stakes. AI is no longer a differentiator—it's an imperative for maintaining media efficiency and creative velocity. For a mid-market agency, AI offers a force multiplier: doing more with the same headcount, winning pitches with data-driven insights, and delivering measurable ROI to clients under intense pricing pressure.

The agency's core business

Evoke Health provides strategy, creative, media, and analytics services exclusively to healthcare clients. This specialization creates a deep moat of domain knowledge but also concentrates the need for compliance and scientific accuracy. The agency's work spans direct-to-consumer (DTC) drug advertising, healthcare professional (HCP) education, and patient support programs. Every deliverable must navigate strict FDA regulations, making the content supply chain both high-stakes and repetitive—a perfect target for AI automation.

Three concrete AI opportunities

1. Intelligent Medical-Legal-Review (MLR) Acceleration. The MLR bottleneck costs agencies millions in delayed campaign launches. Deploying a fine-tuned large language model (LLM) trained on FDA guidance documents and past redacted submissions can pre-review assets, flagging potential compliance issues before human review. This could cut review cycles by 30-50%, directly improving time-to-revenue for clients and agency throughput. ROI is measured in reduced write-offs and faster billing milestones.

2. Predictive Audience Activation. Healthcare audiences are niche and hard to reach. By building a custom predictive model on anonymized claims data, digital behavior, and campaign response history, Evoke can score HCPs and patients on likelihood to engage. This model feeds directly into programmatic buying and CRM journeys, lifting media efficiency by 20-30%. The agency can productize this as a proprietary "Intelligent Audience" offering, commanding premium retainer fees.

3. Generative Creative Production System. A controlled GenAI environment, walled off from public models, can draft initial copy and image concepts for social, display, and email. Human creatives then refine and approve, maintaining brand safety. This shifts the creative process from blank-page syndrome to rapid iteration, slashing production time by half and allowing more A/B testing. The key is building a prompt library and fine-tuning on the agency's own high-performing past work.

Deployment risks for a mid-market agency

The primary risk is governance. Healthcare marketing must be 100% accurate; an AI hallucination about a drug's efficacy is a legal and reputational landmine. Any generative system needs a "human-in-the-loop" checkpoint for all client-facing output. Second, data privacy is paramount. Training models on client data requires strict data processing agreements and anonymization, especially around patient-level information. Third, talent and change management: creatives and account teams may resist tools they perceive as threatening. Success requires transparent communication that AI handles the drudgery, freeing them for strategic work. Finally, cost overruns are a risk if the agency builds versus buys without a clear MVP roadmap. Starting with a focused, high-ROI use case like MLR acceleration is the safest path to building internal buy-in and technical maturity.